Live Quote · NASDAQAVBPHealthcare· Biotechnology

ArriVent BioPharma, Inc.

$10.52▼ 6.57%($-0.74)
MKT CAP $544.13MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
46/100
▌ Weak
60
Valuation
40
Profitability
15
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVBP research report →

Analyst Price Target
$25.29+140.4% vs. today

Range $18 – $29

Analyst RatingBuy
9 Buy0 Hold0 Sell

Price Chart

-47.78% · this period
$34.74$22.61$10.47Nov 20May 26Nov 20
52-Week Range1% of range
Low
$10.33
Current
$10.52
High
$35.83